People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the National Pharmacy Association.

Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to 10–16% (from 16-24%) and revenue growth projections to 8-14% (from 13-21%) at ...

SALT LAKE CITY — It was a first-of-its-kind study conducted at the University of Utah on a drug that has, to date, changed ...

Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...

Scientists are looking into alternative weight loss solutions beyond GLP-1 medications like Mounjaro, Ozempic and Wegovy ...

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...

Apple Fitness Plus is one of CNET’s favorite workout apps thanks to its versatility and various exercise selections. It's affordable at only $11 a month, giving you access to thousands of workouts for ...

Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 medications.

Over time, these drugs have also been found to help people lose weight by slowing digestion, reducing hunger, and making ...

Researchers have found a potential game-changing way to help people lose weight and control blood sugar without the unpleasant side effects of today’s popular drugs like Ozempic.

An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...